显微镜下鼓膜置管术与腺样体切除术联用治疗分泌性中耳炎临床疗效和安全性

Clinical Efficacy and Safety of Tympanostomy Tube Insertion and Adenoidectomy in Treatment of Secretory Otitis Media

目的:探讨腺样体切除术联合显微镜下鼓膜置管术治疗分泌性中耳炎临床疗效和安全性。方法:选择2010年6月至2012年6月在我院耳鼻喉科住院102例分泌性中耳炎患者为研究对象,运用随机数字表法将符合本研究纳入标准和排除标准的患者分为A组和B组,每组各51例患者,A组患者仅给予显微镜下鼓膜置管术治疗,而B组则加用腺样体切除术治疗,两组患者的其他治疗措施完全相同,观察并比较两组患者临床疗效和安全性。结果:B组患者治疗总有效率(96.08%)明显高于A组的(82.35%),总有效率差异有显著性(P<0.05),B组患者语频区气导平均听阈明显优于A组患者的(P<0.05),A组患者的复发率明显高于B组患者的(P<0.05),B组患者完全愈合时间和并发症发生率无明显增加(P<0.05)。结论:腺样体切除术联合显微镜下鼓膜置管术治疗分泌性中耳炎临床疗效确切,具有安全可靠和不良反应少等特点。

Objective： To investigate the clinical efficacy and safety of patients with secretory otitis media by tympanostomy tube operation and adenoidectomy.Methods： The clinical data of 88 patients with secretory otitis media who were in the otolaryngological department in our hospital from June 2010 to June 2012 were collect,they were divided into group A and group B by random number table.The patients in group A were given tympanostomy tube operation,and the patients in group B were given tympanostomy tube operation and adenoidectomy.After one month’ treatment,then the clinical efficacy and safety were compared.Results： After one month’ treatment,the total efficiency rate of group B were significantly higher than that in group A’（96.08% vs 82.35%,P0.05）.Language frequency area gas guide average hearing threshold of group B were significantly better than group A’（P0.05）.The recurrence rate of group A were significantly higher than that in group B’（P0.05）.The adverse reaction rate and complete healing time of the two groups were no different（P0.05）.Conclusion： The clinical efficacy of tympanostomy tube operation and adenoidectomy is superior to patients with secretory otitis media only by tympanostomy tube operationin.It is low recurrence and adverse reaction rate.